Quest VSF Agreements

RNS Number : 8135D

GlaxoSmithKline PLC

18 September 2008

 



Quest Diagnostics Inc - Variable Sales Forward Agreements

GlaxoSmithKline plc (GSK) today confirmed that the Variable Sales Forward Agreements (VSF Agreements) with Lehman Brothers Finance S.A., with respect to a total of 20 million shares of common stock of Quest Diagnostics Inc., have terminated with no material financial impact to GSK expected. GSK has requested that the shares, which were pledged under the VSF Agreements and held in custody by Lehman Brothers Inc, be returned to GSK.

Simon Bicknell 

Company Secretary 

18 September 2008

 

END

 

 

AGREAPNPFSXPEFE